Cargando…

Clinical Impact of Molecular Subtyping of Pancreatic Cancer

Pancreatic ductal adenocarcinoma is a highly lethal malignancy, which has now become the seventh most common cause of cancer death in the world, with the highest mortality rates in Europe and North America. In the past 30 years, there has been some progress in 5-year survival (rates increasing from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xu, Hu, Kai, Bailey, Peter, Springfeld, Christoph, Roth, Susanne, Kurilov, Roma, Brors, Benedikt, Gress, Thomas, Buchholz, Malte, An, Jingyu, Wei, Kongyuan, Peccerella, Teresa, Büchler, Markus W., Hackert, Thilo, Neoptolemos, John P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603393/ https://www.ncbi.nlm.nih.gov/pubmed/34805152 http://dx.doi.org/10.3389/fcell.2021.743908

Ejemplares similares

Corrigendum: Clinical impact of molecular subtyping of pancreatic cancer
por: Zhou, Xu, et al.
Publicado: (2023)

Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival
por: Bailey, Peter, et al.
Publicado: (2023)

Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
por: Zhou, Xu, et al.
Publicado: (2023)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
por: Wei, Kongyuan, et al.
Publicado: (2021)

Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management
por: Schreyer, Daniel, et al.
Publicado: (2022)

Severe acute pancreatitis: surgical indications and treatment
por: Heckler, Max, et al.
Publicado: (2020)

CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
por: Wang, Zhe, et al.
Publicado: (2018)

Adenosine in pancreatic cancer: Emerging combination therapies
por: Roth, Susanne, et al.
Publicado: (2019)

Protocol of a prospective, monocentric phase I/II feasibility study investigating the safety of multimodality treatment with a combination of intraoperative chemotherapy and surgical resection in locally confined or borderline resectable pancreatic cancer: the combiCaRe study
por: Roth, Susanne, et al.
Publicado: (2019)

Assessment of modelling strategies for drug response prediction in cell lines and xenografts
por: Kurilov, Roman, et al.
Publicado: (2020)

Safety and efficacy of TRIANGLE operation applied in pancreatic surgery: a protocol of the systematic review and meta-analysis
por: Wei, Kongyuan, et al.
Publicado: (2022)

Immune Subtypes Based on Immune-Related lncRNA: Differential Prognostic Mechanism of Pancreatic Cancer
por: Zhang, Qiyao, et al.
Publicado: (2021)

Current State of Surgical Management of Pancreatic Cancer
por: Hackert, Thilo, et al.
Publicado: (2011)

Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction Model
por: Gao, Yang, et al.
Publicado: (2021)

Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinoma
por: Chen, Hao, et al.
Publicado: (2022)

Current State of Vascular Resections in Pancreatic Cancer Surgery
por: Hackert, Thilo, et al.
Publicado: (2015)

Type 1 T Helper Cell-Based Molecular Subtypes and Signature Are Associated with Clinical Outcome in Pancreatic Ductal Adenocarcinoma
por: Wei, Ran, et al.
Publicado: (2022)

In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes
por: Li, Weida, et al.
Publicado: (2014)

CRISPR Cas9 in Pancreatic Cancer Research
por: Yang, Hai, et al.
Publicado: (2019)

Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome
por: Körber, Verena, et al.
Publicado: (2023)

Editorial: Translational Insights Into Pancreatic Ductal Adenocarcinoma
por: Bijlsma, Maarten F., et al.
Publicado: (2022)

The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators
por: Kaistha, Brajesh P., et al.
Publicado: (2017)

Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2022)

Effects of neoadjuvant FOLFIRINOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinoma
por: Xie, Li, et al.
Publicado: (2019)

Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer
por: Qian, Hao, et al.
Publicado: (2021)

Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients
por: Ahmed, Azaz, et al.
Publicado: (2023)

Screening Technologies for Target Identification in Pancreatic Cancer
por: Michl, Patrick, et al.
Publicado: (2010)

Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma
por: Xue, Shengbai, et al.
Publicado: (2022)

Blimp-1/PRDM1 and Hr3/RORβ specify the blue-sensitive photoreceptor subtype in Drosophila by repressing the hippo pathway
por: Bunker, Joseph, et al.
Publicado: (2023)

Distal Bile Duct Cancer: Radical (R0 > 1 mm) Resection Achieves Favorable Survival
por: Tjaden, Christine, et al.
Publicado: (2023)

Impaired autophagy increases susceptibility to endotoxin-induced chronic pancreatitis
por: Xia, L., et al.
Publicado: (2020)

A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer
por: Ge, Weiyu, et al.
Publicado: (2022)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020)

Toward Generating Subtype-Specific Mesencephalic Dopaminergic Neurons in vitro
por: Cardoso, Tiago, et al.
Publicado: (2020)

Characterization of the Different Subtypes of Immune Cell Infiltration to Aid Immunotherapy
por: Li, Zhenqing, et al.
Publicado: (2022)

Autophagy Blockage Reduces the Incidence of Pancreatic Ductal Adenocarcinoma in the Context of Mutant Trp53
por: Mainz, Laura, et al.
Publicado: (2022)

Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary?
por: Hu, Ye, et al.
Publicado: (2020)

Tmc Reliance Is Biased by the Hair Cell Subtype and Position Within the Ear
por: Zhu, Shaoyuan, et al.
Publicado: (2021)

Metabolic and Immunological Subtypes of Esophageal Cancer Reveal Potential Therapeutic Opportunities
por: King, Ryan J., et al.
Publicado: (2021)

Identification of HCC Subtypes With Different Prognosis and Metabolic Patterns Based on Mitophagy
por: Wang, Yao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_79ph9lbtfcse4lhtqk1tqcmaon